Dr Goldhaber reviews a Canadian study on the use of D-dimer testing to predict recurrent VTE.

A rabid Glasgow Celtic fan explains how he escaped the violent streets of Belfast, Northern Ireland to become one of the world's leading heart-failure researchers to new series host Dr Magnus Ohman.

Are women at risk for AF less likely to receive oral anticoagulation than men? Dr Goldhaber reviews data from a global registry.

The FDA Advisory Committee ruling on PCSK9 drugs, sitagliptin and CV risk, PPI use and MI risk, and the role of stress in heart disease are reviewed by Dr Mandrola.

Dr John Mandrola reviews studies on FFR-CT for evaluation of chest pain, anticoagulation after AF ablation, a novel treatment protocol in the ER for patients with AF, mindfulness therapy, and shared-decision making.

Selma Mohammed and Victor Montori explore the merits of shared decision making and highlight a tool to facilitate the discussion on whether to take a statin for primary prevention.

From HRS 2015 in Boston, Dr Mandrola addresses MICRA pacing, LV endocardial pacing for CRT, MRI-safe ICDs, NOACs before AF ablation, Botox for AF, His-bundle pacing, ABIM-MOC and Contrave Light.

Dr Goldhaber's poignant tribute to his colleague who was shot and killed at Brigham and Women's hospital.

LaPrincess Brewer interviews Bernard Gersh on the fundamentals of atrial fibrillation in heart failure.

Which patients are at risk for cachexia and how do you diagnose and treat it? Dr Pina gets the answers from an expert in the field, Dr Stefan Anker.